Zeng Q, Oliva VM, Moro MÁ et al. Circ Res. 2024 Mar 15;134(6):791-809. doi: 10.1161/CIRCRESAHA.123.323619. Epub 2024 Mar 14. PMID: 38484032
Publicaciones: marzo 2024
Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles
Sarraj A, Hassan AE, Abraham MG et al. JAMA. 2024 Mar 5;331(9):750-763. doi: 10.1001/jama.2024.0572. PMID: 38324414
Lack of the Histone Deacetylase SIRT1 Leads to Protection against Endoplasmic Reticulum Stress through the Upregulation of Heat Shock Proteins
Latorre J, de Vera N, Santalucía T et al. Int J Mol Sci. 2024 Mar 1;25(5):2856. doi: 10.3390/ijms25052856. PMID: 38474102
Rationale and Design of the Statins Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Marchina S, Yeatts SD, Foster LD et al. Cerebrovasc Dis. 2024 Mar 16. doi: 10.1159/000538195. Online ahead of print. PMID: 38493765
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds
Prats-Sanchez L, Camps-Renom P, Nash PS, Wilson D et al. Neurology. 2024 Apr 9;102(7):e209173. doi: 10.1212/WNL.0000000000209173. Epub 2024 Mar 12. PMID: 38471056
https://pubmed.ncbi.nlm.nih.gov/38471056/
Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial
Chen M, Joshi KC, Kolb B et al. J Neurointerv Surg. 2024 Mar 12:jnis-2023-021219. doi: 10.1136/jnis-2023-021219. Online ahead of print. PMID: 38471760
Time of the day and season distribution among stroke code subtypes: differences between ischemic stroke, intracranial hemorrhage, and stroke mimic
Menéndez Albarracín A, Valls Carbó A, Rabaneda Lombarte N et al. Front Neurol. 2024 Mar 26;15:1372324. doi: 10.3389/fneur.2024.1372324. eCollection 2024. PMID: 38595853
The Role of Epigenetics in Brain Aneurysm and Subarachnoid Hemorrhage: A Comprehensive Review
Fernández-Pérez I, Macias-Gómez A, Suárez-Pérez A et al. Int J Mol Sci. 2024 Mar 19;25(6):3433. doi: 10.3390/ijms25063433. PMID: 38542406
https://pubmed.ncbi.nlm.nih.gov/38542406/
Abstract: This comprehensive review explores the emerging field of epigenetics in intracranial aneurysm (IA) and aneurysmal subarachnoid hemorrhage (aSAH). Despite recent advancements, the high mortality of aSAH needs an understanding of its underlying pathophysiology, where epigenetics plays a crucial role. This review synthesizes the current knowledge, focusing on three primary epigenetic mechanisms: DNA methylation, non-coding RNA (ncRNA), and histone modification in IA and aSAH. While DNA methylation studies are relatively limited, they suggest a significant role in the pathogenesis and prognosis of IA and aSAH, highlighting differentially methylated positions in genes presumably involved in these pathologies. However, methodological limitations, including small sample sizes and a lack of diverse population studies, temper these results. The role of
ncRNAs, particularly miRNAs, has been more extensively studied, but there are still few studies focused on histone modifications. Despite methodological challenges and inconsistent findings, these studies underscore the involvement of miRNAs in key pathophysiological processes, including vascular smooth muscle regulation and the inflammatory response. This review emphasizes methodological challenges in epigenetic research, advocating for large-scale epigenome-wide associationnstudies integrating genetic and environmental factors, along with longitudinal studies. Such research could unravel the complex mechanisms behind IA and aSAH, guiding the development of targeted therapeutic approaches.
Funding: This research was supported in part by Spain’s Ministry of Health (Instituto de Salud Carlos III, Fondos FEDER, (RICORS-ICTUS/RD21/0006/0021)).
Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies
Olmo ED, Barboza B, Delgado-Esteban M et al. Bioorg Chem. 2024 Mar 3;146:107255. doi: 10.1016/j.bioorg.2024.107255. Online ahead of print. PMID: 38457955
Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke
Correa-Paz C, Pérez-Mato M, Bellemain-Sagnard M et al. J Cereb Blood Flow Metab. 2024 Mar 4:271678X241237427. doi: 10.1177/0271678X241237427. Online ahead of print. PMID: 38436292